Evidence mapPaperPMID 36542467Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults].

Yuline Varela-Vega, Ivonne Analí Roy-García, Marcela Pérez-Rodríguez, Lubia Velázquez-López

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuline Varela-VegaInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 28, Servicio de Consulta Externa. Ciudad de México, México.ORCID 0000-0002-0426-763X
Ivonne Analí Roy-GarcíaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud, División de Investigación Clínica. Ciudad de México, México.ORCID 0000-0002-1859-3866
Marcela Pérez-RodríguezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud, División de Investigación Clínica. Ciudad de México, México.ORCID 0000-0003-3417-3201
Lubia Velázquez-LópezInstituto Mexicano del Seguro Social, Hospital General Regional No. 1 "Dr. Carlos Mac Gregor Sánchez Navarro", Unidad de Investigación. Ciudad de México, México.ORCID 0000-0002-1189-3399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insulin resistance (IR) is a state prior to the development of type 2 diabetes (T2D) and it is reversible with lifestyle modification. However, it is underdiagnosed due to the difficulty in its measurement. Objective: To evaluate the diagnostic performance of the FINDRISC questionnaire to identify IR. Material and methods: An analytical cross-sectional study was performed in adults aged 20 to 60 years without previous diagnosis of T2D. Those using steroids and pregnant women were excluded. IR was diagnosed through the Triglycerides/glucose index. A ROC curve was used to establish the cut-off point for the diagnosis of IR. Sensitivity, specificity, predictive values and likelihood ratios were calculated. Risk measurement for IR was performed with the FINDRISC instrument. Results: A total of 253 participants were included, with a prevalence of IR of 60.8%. The area under the curve of the FINDRISC instrument was 0.813 (95% confidence interval [95% CI] 0.759-0.865), with a cut-off point of 8. Sensitivity was 94.8% and specificity was 48.5%, positive predictive value was 74% and negative 86%, with a positive likelihood ratio of 1.84 and a negative of 0.11. Conclusions: The FINDRISC instrument is a useful screening tool to identify subjects with IR at the first level of care. A score ≥ 8 identifies subjects with IR.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAdultBlood GlucoseCross-Sectional StudiesFemaleHumansRisk FactorsSurveys and QuestionnairesBlood GlucoseFINDRISCInsulin ResistanceSensitivity and SpecificityTriglyceride Glucose Index

Identifiers

PMID36542467
PMCPMC10395935

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.